HOME >> BIOLOGY >> NEWS
FDA clears for market new diagnostic test for lupus

SEATTLE The U.S. Food and Drug Administration has cleared for market a new screening test for lupus developed by researchers at the Fred Hutchinson Cancer Research Center. The test is considered the first significant diagnostic breakthrough for systemic lupus erythematosis, or SLE, in more than four decades.

The test is expected to pick up the 20 percent of SLE cases that previously fell through the cracks because they could not be detected by the most widely used, standard screening test.

Lupus is a chronic disorder in which a persons immune system attacks the body. SLE is the most severe and potentially fatal form of the disease, which causes inflammation of connective tissue throughout the body, from the joints to the kidneys. Because symptoms range from skin rash and mild fatigue to organ failure, diagnosis can be difficult.

While the majority of lupus patients produce antibodies to their own tissue that can be detected with a blood test thats been available since the early 1960s, about one-fifth of patients those who do not make such antibodies often go undiagnosed.

The new test, developed by Mark Roth, Ph.D., a member of Fred Hutchinsons Basic Sciences Division, promises to bridge that diagnostic gap.

This test will improve the ability for doctors to make correct decisions when diagnosing SLE, and we also have evidence that this test is of value in determining where in the body the disease will present itself, said Roth, also an affiliate associate professor of biochemistry at the University of Washington School of Medicine.

Two years ago, in the August 2000 issue of Arthritis and Rheumatism, Roth and colleagues at Fred Hutchinson and the University of Washington, in collaboration with New York Medical College rheumatologist Robert G. Lahita, M.D., Ph.D., first reported the discovery that molecules called SR proteins are particularly useful biomarkers for lupus because the majority of patients produce antibodies to them.

T
'"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
28-Aug-2002


Page: 1 2

Related biology news :

1. Wildland fires: After the smoke clears
2. FDA clears Berlex Laboratories Mirena (R), new form of long-acting contraception meets need for U.S. women
3. Flame retardants found on supermarket shelves
4. Huge market for forest moss raises concerns
5. Institute for OneWorld Health CEO advocates focus first on developing world markets
6. East Asian governments urged to harness market forces to improve environment, save money
7. Astrazeneca announces EU marketing approval for Faslodex(TM)
8. Asias biodiversity vanishing into the marketplace
9. Avian flu: Shut down wild bird markets, experts say
10. Ethical guidelines needed before nutrigenomic groceries come to market
11. Worm farmers wriggle into US market

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to lead ... near term focus on Type 2 diabetes and associated comorbidities. , Justin brings ... areas and classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ ...
(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first in ... on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor ... live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition ...
(Date:7/1/2020)... ... 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) nonprofit ... aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: John ... the organization’s initiatives and overall vision. , "Senior Fellows are more than advisors; ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering patients ... million stem cells total, patients may choose which extremities they would like treated. , ... (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the ... the history of eSource, the reasons it did not take off as quickly as ... source, the industry is moving towards capturing data electronically for clinical trials and then ...
(Date:7/18/2020)... MILWAUKEE (PRWEB) , ... July 16, 2020 , ... “We ... at Third Wave Bioactives. “It’s the only technology of its kind on the market ... flavor of onions with the protective capacity of traditional cultured ingredients, creating a natural ...
(Date:7/10/2020)... ... 2020 , ... In most research using the zebrafish model, ... in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the past ... the zebrafish model to investigate the causes of leukaemia and its relationship with ...
Breaking Biology Technology:
Cached News: